Drug Information

Drug General Information
Drug ID
D0IQ1V
Former ID
DIB009121
Drug Name
CIGB-300
Synonyms
P15; IGBC-300; P15-Tat
Indication Cervical cancer [ICD9: 180; ICD10:C53] Phase 3 [532981]
Company
Center for Genetic Engineering and Biotechnology
Target and Pathway
Target(s) Casein kinase 2 Target Info Modulator [532981]
References
Ref 532981Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models. Mol Clin Oncol. 2014 Nov;2(6):935-944. Epub 2014 Jul8.
Ref 532981Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models. Mol Clin Oncol. 2014 Nov;2(6):935-944. Epub 2014 Jul8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.